Expert neurologists review updates in the management of Myasthenia Gravis.
EP. 2: Misdiagnosis Associated With Myasthenia Gravis and Importance of Multidisciplinary TeamsJune 13th 2022
Expert panelists discuss misdiagnosis of myasthenia gravis and consider the question of whether this condition should be treated by community physicians.
EP. 4: Use of AChEI and Immunosuppressives in Managing SymptomsJune 20th 2022
James F. Howard Jr., MD and Nicholas J. Silvestri MD, FAAN, share insights regarding acetylcholinesterase inhibitors and immunosuppressive therapy as first-line treatments for patients with myasthenia gravis.
EP. 12: FcRns Inhibitors for the Treatment of Myasthenia GravisJuly 18th 2022
James F. Howard Jr., MD and Nicholas J. Silvestri MD, FAAN, discuss the efficacy and safety of FcRn inhibitors, as well as consider their role in the rapidly evolving treatment landscape.
EP. 14: Unmet Needs and Future Directions in Myasthenia GravisJuly 25th 2022
James F. Howard Jr., MD, and Nicholas J. Silvestri MD, FAAN, deliver parting thoughts on the state of the myasthenia gravis treatment, focusing on current deficits and future prospects.